Mahindra & Mahindra Incorporates New Step-Down Subsidiary Ultrogen Hybren

Anand Mahindra-led, Mahindra & Mahindra Limited (M&M), the flagship company of the Mahindra Group has expanded its presence in the renewable energy sector by incorporating a new step-down subsidiary, Ultrogen Hybren Private Limited.

On December 30, 2024, Mahindra & Mahindra share price traded down 0.95%, reaching an intra-low high of ₹3,021 at 9:32 AM (IST). According to BSE data, the stock recorded a total traded volume of 4776 shares, resulting in a turnover of ₹1.44 lakh.

Approval and Ownership Structure

The Ministry of Corporate Affairs approved the incorporation of Ultrogen Hybren Private Limited on December 29, 2024. The subsidiary, based in Mumbai, Maharashtra, is wholly owned by Mahindra Susten Private Limited (MSPL), a Mahindra Holdings Limited (MHL) subsidiary. MHL, in turn, is a wholly owned subsidiary of M&M, making Ultrogen Hybren a step-down subsidiary of the parent company.

The company was incorporated with an acquisition cost of ₹15 lakh, comprising 1,50,000 equity shares at ₹10 per share. MSPL, holding 100% of Ultrogen Hybren’s share capital, underscores M&M’s focus on renewable energy ventures.

Ultrogen Hybren’s Role in Renewable Energy

Ultrogen Hybren Private Limited will operate in the renewable energy sector, focusing on producing and selling power and electricity. The company aims to serve as an Independent Power Producer (IPP) and offer distributed energy solutions, including rooftop solar installations for commercial, industrial, institutional, and residential segments.

Leveraging various renewable energy sources and energy storage systems, Ultrogen Hybren is set to cater to India’s growing demand for sustainable and clean energy. This initiative aligns with Mahindra Group’s broader vision of promoting green energy and supporting India’s renewable energy goals.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.